Pretty sure I recall Dr Rowe saying a 50% slowing in disease progression equates to a four-fold extension of life expectancy, which is a little bit mind blowing. It'd be interesting to see what would happen if the medication was stopped, when rapamycin was ceased after a month in the Ike the mouse study the benefits continued. Although, if I were a trial participant I'd be about as open to stopping as I would be to dancing bare arsed in a bum rape factory.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-885
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.010(5.26%) |
Mkt cap ! $71.26M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 18.0¢ | $184.0K | 982.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 176820 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 167405 | 5 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
-0.010 ( 5.26 %) |
||||
| Open | High | Low | Volume | ||
| 19.5¢ | 19.5¢ | 18.0¢ | 438529 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| PAA (ASX) Chart |